These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29261656)

  • 21. Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.
    Deardorff WJ; Shobassy A; Grossberg GT
    Expert Rev Neurother; 2015 Jan; 15(1):7-17. PubMed ID: 25495510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of α7 nicotinic receptor agonist PHA-543613 on spatial memory performance of rats in two distinct pharmacological dementia models.
    Bali ZK; Inkeller J; Csurgyók R; Bruszt N; Horváth H; Hernádi I
    Behav Brain Res; 2015 Feb; 278():404-10. PubMed ID: 25447295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
    Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
    ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
    de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
    Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats: a pharmacokinetic and behavioral study.
    van Goethem NP; Prickaerts J; Welty D; Flood DG; Koenig G
    Behav Pharmacol; 2015 Jun; 26(4):403-6. PubMed ID: 25794332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
    Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
    Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of nicotinic α7 and α4/β2 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates.
    Azimi M; Oemisch M; Womelsdorf T
    Psychopharmacology (Berl); 2020 Apr; 237(4):997-1010. PubMed ID: 31865424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropisetron and its targets in Alzheimer's disease.
    Hashimoto K
    Expert Opin Ther Targets; 2015 Jan; 19(1):1-5. PubMed ID: 25399811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
    Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
    Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.
    Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE
    Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia.
    Karamihalev S; Prickaerts J; van Goethem NP
    Behav Brain Res; 2014 Oct; 272():248-51. PubMed ID: 25036424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors.
    Van Kampen M; Selbach K; Schneider R; Schiegel E; Boess F; Schreiber R
    Psychopharmacology (Berl); 2004 Apr; 172(4):375-83. PubMed ID: 14727003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.
    Taffe MA; Weed MR; Gutierrez T; Davis SA; Gold LH
    Psychopharmacology (Berl); 2002 Mar; 160(3):253-62. PubMed ID: 11889494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment.
    Talpos JC; Aerts N; Fellini L; Steckler T
    Pharmacol Biochem Behav; 2014 Jul; 122():97-106. PubMed ID: 24662914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.
    Russo P; Del Bufalo A; Frustaci A; Fini M; Cesario A
    Curr Pharm Des; 2014; 20(38):6014-21. PubMed ID: 24641224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats.
    van der Staay FJ; Bouger PC
    Behav Brain Res; 2005 Jan; 156(1):1-10. PubMed ID: 15474645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
    Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
    J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
    Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.
    Lange HS; Cannon CE; Drott JT; Kuduk SD; Uslaner JM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):442-50. PubMed ID: 26446308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization.
    Sinha N; Karche NP; Verma MK; Walunj SS; Nigade PB; Jana G; Kurhade SP; Hajare AK; Tilekar AR; Jadhav GR; Thube BR; Shaikh JS; Balgude S; Singh LB; Mahimane V; Adurkar SK; Hatnapure G; Raje F; Bhosale Y; Bhanage D; Sachchidanand S; Dixit R; Gupta R; Bokare AM; Dandekar M; Bharne A; Chatterjee M; Desai S; Koul S; Modi D; Mehta M; Patil V; Singh M; Gundu J; Goel RN; Shah C; Sharma S; Bakhle D; Kamboj RK; Palle VP
    J Med Chem; 2020 Feb; 63(3):944-960. PubMed ID: 31755711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.